BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9420345)

  • 1. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug treatment of Graves' ophthalmopathy].
    Prummel MF; Wiersinga WM
    Ned Tijdschr Geneeskd; 1990 May; 134(19):938-40. PubMed ID: 1693417
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
    Bogazzi F; Martino E; Bartalena L
    J Endocrinol Invest; 2003 Feb; 26(2):174-6. PubMed ID: 12739747
    [No Abstract]   [Full Text] [Related]  

  • 5. Is Graves ophthalmopathy a preventable disease?
    Keltner JL
    Arch Ophthalmol; 1998 Aug; 116(8):1106-7. PubMed ID: 9715694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis.
    Ren Z; Qin L; Wang JQ; Li Y; Li J; Zhang RG
    Exp Clin Endocrinol Diabetes; 2015 May; 123(5):317-22. PubMed ID: 25988881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy and Graves' ophthalmopathy.
    Bartalena L
    Nucl Med Commun; 2002 Nov; 23(11):1143-5. PubMed ID: 12411845
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial.
    Braga M; Walpert N; Burch HB; Solomon BL; Cooper DS
    Thyroid; 2002 Feb; 12(2):135-9. PubMed ID: 11916282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine and Graves' ophthalmopathy reconsidered.
    Noury AM; Stanford MR; Graham EM
    Nucl Med Commun; 2001 Nov; 22(11):1167-9. PubMed ID: 11606880
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reduced antithyroid agents as a result of radioiodine therapy?].
    Maka D; Schicha H; Körber C; Schneider P; Reiners C
    Nuklearmedizin; 2000; 39(2):N25-6. PubMed ID: 10768174
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies.
    Cooper DS
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3474-81. PubMed ID: 12915620
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-thyroid drug treatment before radioiodine in patients with Graves' disease: soother or menace?
    Perros P
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):1-2. PubMed ID: 10931073
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basedow's disease. Individual therapy of is great significance].
    Hörmann R
    MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
    [No Abstract]   [Full Text] [Related]  

  • 16. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment].
    Kamoun M; Abid H; Lamine F; Slimane H; Haddad A
    Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient.
    Das PK; Wherrett D; Dror Y
    Pediatr Blood Cancer; 2007 Aug; 49(2):210-2. PubMed ID: 16456859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
    Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
    N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.
    Pedro AB; Romaldini JH; Takei K
    Neuroimmunomodulation; 2011; 18(1):45-51. PubMed ID: 20628263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment.
    Rivkees SA; Sklar C; Freemark M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3767-76. PubMed ID: 9814445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.